Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Nov 22, 2024

SELL
$6.3 - $8.84 $170,100 - $238,680
-27,000 Closed
0 $0
Q4 2021

Nov 22, 2024

BUY
$6.02 - $11.43 $162,540 - $308,610
27,000 New
27,000 $235 Million
Q4 2020

Nov 22, 2024

BUY
$23.25 - $37.73 $627,750 - $1.02 Million
27,000 New
27,000 $661 Million

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $88.1M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Erste Asset Management Gmb H Portfolio

Follow Erste Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.